Scott Jordan
CIK 1769747 · Chief Financial Officer · last filed 2025-03-19
Scott Jordan is a Chief Financial Officer who has filed 5 SEC Form 4 insider transactions across 2 companies since 2019. Across all open-market trades the lifetime net is +$10.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
5
$10.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Zomedica Corp. (ZOM) Delisted | Chief Financial Officer | — | $0.10 | — | $0 | 1 | 2025-01-03 |
| Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Chief Business Officer | 31,609 | $0.84 | $26.6K | $10.2K | 3 | 2020-02-18 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-19 | — | Buy (P) | +300,000 | $18.6K | |
| 2025-01-03 | Zomedica Corp. (ZOM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-18 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Buy (P) | +11,300 | $10.2K | EDGAR |
| 2019-09-13 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-12 | Salarius Pharmaceuticals, Inc. (SLRX) Delisted | Grant (A) | — | $0 | EDGAR |